Want to see MYGN full AI Analyst Report?
Myriad Genetics (MYGN) Ownership Overview
5.87% Insiders
15.77% Mutual Funds
11.62% Other Institutional Investors
18.21% ETFs
48.53% Public Companies and
Individual Investors
The ownership structure of Myriad Genetics (MYGN) stock is a mix of institutional, retail, and individual investors. Approximately 45.60% of the company’s stock is owned by Institutional Investors, 5.87% is owned by Insiders, and 48.53% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 14, 2026 | xxxxxxxxxxxxx | $27600 | |
Mar 09, 2026 | xxxxxxxxxxxxx | $199600 | |
Feb 27, 2026 | xxxxxxxxxxxxx | $494487 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $1076483 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $67081 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $164471 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $227469 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,411,978 | Institution | 5.66% | 18,508,965 | |
| 5,152,467 | Institution | 5.39% | 17,621,437 | |
| 4,353,487 | Institution | 4.55% | 14,888,926 | |
| 3,827,024 | Institution | 4.00% | 13,088,422 | |
| 3,571,280 | Institution | 3.73% | 12,213,778 | |
| 1,621,203 | Institution | 1.69% | 5,544,514 | |
| 1,373,473 | Institution | 1.44% | 4,697,278 | |
| 1,190,896 | Institution | 1.25% | 4,072,864 | |
| 1,181,362 | Institution | 1.24% | 4,040,258 | |
| 1,068,083 | Insider | 1.12% | 3,652,844 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,827,024 | Institution | 4.00% | 13,088,422 | |
| 1,621,203 | Institution | 1.69% | 5,544,514 | |
| 1,373,473 | Institution | 1.44% | 4,697,278 | |
| 1,181,362 | Institution | 1.24% | 4,040,258 | |
| 1,036,333 | Institution | 1.08% | 3,544,259 | |
| 914,577 | Institution | 0.96% | 3,127,853 | |
| 798,252 | Institution | 0.83% | 2,730,022 | |
| 523,833 | Institution | 0.55% | 1,791,509 | |
| 445,703 | Institution | 0.47% | 1,524,304 | |
| 436,478 | Institution | 0.46% | 1,492,755 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,101,801 | Institution | 3.24% | 10,422,051 | |
| 2,881,677 | Institution | 3.01% | 8,241,596 | |
| 2,371,823 | Institution | 2.48% | 8,111,635 | |
| 1,093,674 | Institution | 1.14% | 3,127,908 | |
| 854,602 | Institution | 0.89% | 2,922,739 | |
| 779,918 | Institution | 0.82% | 2,620,524 | |
| 757,702 | Institution | 0.79% | 2,545,879 | |
| 665,004 | Institution | 0.70% | 2,274,314 | |
| 518,278 | Institution | 0.54% | 1,482,275 | |
| 446,684 | Institution | 0.47% | 1,500,858 |
FAQ
Who Owns Myriad Genetics (MYGN)?
According to the latest TipRanks data, approximately 11.62% of the company's stock is held by institutional investors, 5.87% is held by insiders, and 48.53% is held by retail investors.
What percentage of Myriad Genetics (MYGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.62% of Myriad Genetics (MYGN) stock is held by institutional investors.
What percentage of Myriad Genetics (MYGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.53% of Myriad Genetics (MYGN) stock is held by retail investors.
Who owns the most shares of Myriad Genetics (MYGN)?
Larry Robbins owns the most shares of Myriad Genetics (MYGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.